Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma.
Xiaoyan HeChao QinYanding ZhaoLin ZouHui ZhaoChao ChengPublished in: Cancer communications (London, England) (2021)
Our integrative gene signature model shows a significantly improved forecast performance with prognostic and predictive information, and thereby can be served as a biomarker to stratify NB patients for prognosis evaluation and surveillance programs.